Letters Data sharing on request for trials

Open access to economic outcome data will help to bridge the gap between clinical trials and clinical guidelines

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h3091 (Published 08 June 2015) Cite this as: BMJ 2015;350:h3091
  1. Joseph A Ladapo, assistant professor of population health and medicine1,
  2. Yixin Fang, assistant professor of population health2,
  3. Karina W Davidson, professor of behavioral medicine in medicine, cardiology, and psychiatry3,
  4. R Scott Braithwaite, professor of population health and medicine1
  1. 1New York University School of Medicine, 227 E 30th Street, New York, NY 10016, USA
  2. 2New York University School of Medicine, 650 First Avenue, New York, NY 10016
  3. 3Columbia University Medical Center, 622 W 168th Street, New York, NY 10032
  1. joseph.ladapo{at}nyumc.org

Buoyed by a burgeoning medical culture of “appropriate use” and rising doctor awareness of the financial ruin that threatens many patients who navigate expensive treatments in pursuit of better health, medical specialist societies have grown increasingly vocal about integrating economic value in their clinical guidelines.1 These encouraging developments are, however, threatened by a worsening decline in the generalisability of randomised controlled trials, a concern supported by widening differences between the characteristics …

View Full Text

Log in

Log in through your institution


* For online subscription